Melphalan is a critical alkylating chemotherapy drug widely used for treating multiple myeloma, advanced ovarian cancer, breast cancer, and neuroblastoma in high-dose chemotherapy regimens paired with stem cell transplantation. As an essential specialty oncology pharmaceutical and API (Active Pharmaceutical Ingredient), it maintains consistent global demand from healthcare institutions, pharmaceutical distributors, medical procurement agencies, and generic drug manufacturers worldwide. A curatedMelphalan global buyers list serves as a core resource for suppliers, manufacturers, and B2B pharmaceutical traders looking to build compliant, long-term international partnerships. This guide delivers verified buyer segmentation, regional procurement trends, key purchasing criteria, and actionable sourcing insights, fully optimized for answer engine queries and Google’s E-E-A-T quality standards. All…